Pendrea Bio
PrivateLast Round
Grant
Dec 14, 2022
Total Funding Raised
$4.1M
Company Overview
Pendrea Bio is a biotechnology company that develops nanotechnology platforms for the delivery of therapeutic agents, including RNA therapeutics and cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pendrea Bio Comparables
Compare Pendrea Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QurCan Therapeutics | 83% | |
| Duo Oncology | 79% | |
| Acuitas Therapeutics | 79% |
Pendrea Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 14, 2022 | ||||
| Grant | Oct 5, 2015 | ||||
| Grant | Aug 20, 2012 |
Pendrea Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Ben Franklin Technology Partners of Central & Northern PA | VC Round |
| Pennsylvania Department of Health | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 14, 2022
$3K round led by Innovation Partnership
- Aug 20, 2012
Received grant from the Pennsylvania Department of Health.
Pendrea Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access